You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) POVIDONES


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing POVIDONES excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing POVIDONES excipient

Market Dynamics and Financial Trajectory for Povidones (Polyvinylpyrrolidone - PVP)

Last updated: March 6, 2026

What is the Current Market Size and Growth Rate for Povidones?

The global povidone market was valued at approximately USD 750 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of roughly 6.5% from 2023 to 2030.

Which Factors Drive Demand for Povidones?

Pharmaceutical Industry

Povidones are used extensively as excipients in drug formulations, particularly as binders, disintegrants, and solubilizers in tablets and capsules. The growing prevalence of chronic diseases and expanding pharmaceutical pipelines increase demand. In 2022, pharmaceuticals accounted for 60% of povidone consumption.

Personal Care and Cosmetics

The cosmetics sector utilizes povidones for film-forming, binding, and thickening. Rising beauty and skincare markets in Asia-Pacific regions drive demand, representing about 20% of the total market in 2022.

Other End-Uses

Industries like food packaging, biotechnology, and industrial applications account for 20% of market volume. These sectors primarily use povidones for their binding, solubilizing, and stabilizing properties.

Who Are the Leading Market Players?

Company Market Share (2022) Notable Features
BASF SE 25% Extensive product portfolio, R&D investment in advanced PVP grades
Ashland Global Holdings Inc. 20% Focus on high-purity grades for pharma and cosmetics
Sekisui Chemical Co. Ltd. 15% Innovative formulations for pharmaceutical applications
Anhui Sunhere Pharmaceutical Co. 10% Focuses on regional markets with competitive pricing
Other Players 30% Including various regional and specialty manufacturers

How Do Regulatory Policies Affect Market Optimization?

Pharmaceutical excipients like povidone are regulated by agencies including the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other national authorities. These agencies require compliance with good manufacturing practices (GMP). Strict regulation enhances market security but may increase costs for manufacturers.

Global standards, such as the European Pharmacopoeia specifications for povidone, influence formulation stability, impurity levels, and batch consistency. Regulatory approval for new grades or applications requires rigorous testing, impacting market entry timelines.

What Are the Major Market Challenges and Risks?

  • Supply Chain Disruptions: Dependency on raw materials like vinylmonomers and monomer-grade pyrrolidones can cause vulnerabilities.
  • Regulation Stringency: Tighter regulations for pharmaceutical and cosmetic applications increase R&D and compliance costs.
  • Environmental Concerns: Movement towards sustainable manufacturing practices may necessitate redesigning processes, potentially raising capital expenditure.

What Is the Financial Trajectory for Manufacturers?

Revenue Growth

Top producers report stable revenue increases aligned with the global pharma expansion. Earnings before interest, taxes, depreciation, and amortization (EBITDA) margins for leading firms hover around 15-25%.

Investment Trends

Investments are shifting towards bio-ready, high-purity, and biodegradable grades. R&D expenditures among primary companies account for 5-10% of annual turnover. Capacity expansions focus on Asia-Pacific and Europe, where market growth is highest.

Pricing Dynamics

Prices for povidones range from USD 3 to USD 6 per kilogram, depending on purity grade and regional logistics. Higher-grade pharmaceutical povidones command premiums of up to 25%. Price pressure from regional manufacturers in China and India remains ongoing.

How Do Future Trends Influence Market Value?

  • Innovations in PVP Grades: Development of water-soluble, bio-safe, and eco-friendly grades will diversify applications.
  • Biopharmaceutical Expansion: Increased use in biologics and biosimilars will sustain demand growth.
  • Digital Integration: Adoption of automated manufacturing and real-time quality monitoring will reduce costs and improve compliance.

Key Areas for Investment and R&D Focus

  • Developing stable high-purity grades for injectable and parenteral formulations.
  • Creating biodegradable and sustainable PVP variants.
  • Expanding manufacturing capacity in emerging markets with supportive regulatory environments.

Final Considerations

The povidone market is poised for steady growth driven by pharmaceutical sector expansion and cross-industry applications. Market participants should monitor regulatory trends, raw material supply chains, and innovation pace to optimize financial performance.

Key Takeaways

  • Market was USD 750 million in 2022, with a 6.5% CAGR through 2030.
  • Major uses are pharmaceuticals (60%) and cosmetics (20%).
  • Leading players include BASF (25%) and Ashland (20%), focusing on high-purity grades.
  • Growth is driven by biopharmaceuticals and demand for eco-friendly grades.
  • Price range is USD 3-6/kg; premiums for pharma-grade povidone.

FAQs

1. What factors influence pricing of povidones?
Pricing varies with grade purity, application, regional supply and demand, and raw material costs.

2. How does regulation affect market growth?
Regulatory standards increase compliance costs but also secure market integrity and expand export opportunities.

3. Which regions show the highest growth potential?
Asia-Pacific regions, especially China and India, with expanding manufacturing bases and lower costs.

4. Are bio-based or biodegradable povidones available?
Research is ongoing, but commercially available biodegradable grades are limited; innovation focus is increasing.

5. What is the outlook for small and niche manufacturers?
Niche players focusing on specialty grades or regional markets may find growth opportunities, but they face competition from large, diversified firms.


Sources:
[1] MarketsandMarkets. (2022). Povidone Market.
[2] Grand View Research. (2023). Pharmaceutical Excipients Market.
[3] European Pharmacopoeia. (2022). Monograph for Povidone.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.